›Portfolio Companies

Past, Present and Future Leaders

The managing directors of IWHP are proud and privileged to have partnered with visionary management teams who are shaping the future of Biotech, Medical Devices and Healthcare IT. The groundbreaking businesses they have created are representative of the industry-leading companies that InterWest has helped build over the last three decades.

Our Companies

VENTURE INVESTING IN BREAKTHROUGH HEALTHCARE COMPANIES

MacroGenics

portfoliocompanies

company snapshot

MacroGenics

Founded in 2000, MacroGenics (MGNX) is a biotechnology company headquartered in Rockville, Maryland that focuses on the development, manufacture, and commercialization of immunotherapeutics for autoimmune disorders, cancer, and infectious diseases. The company's proprietary Fc engineering technology offers ways of improving antibody function, such as enhancing its ability to eliminate cancer cells, cells that contribute to autoimmune disorders, or those infected with certain pathogens. The company is developing first-in-class product candidates from its autoimmunity, oncology and infectious disease portfolios.

website
www.macrogenics.com
Leadership
Follow The Company
Investment Team
Recent News
Scott Koenig, CEO